Overview

Tranexamic Acid for the Prevention of Blood Loss in High Risk Delivered Women

Status:
Completed
Trial end date:
2020-10-10
Target enrollment:
Participant gender:
Summary
Postpartum hemorrhage and its complications are very well known causes for maternal mortality .Uterine atony is the most common cause for postpartum hemorrhage
Phase:
N/A
Details
Lead Sponsor:
Hawler Medical University
Treatments:
Tranexamic Acid